Nuvation Bio
Price & Volume
Stats
See moreOpen | $8.53 |
Previous Close | $8.49 |
Day Range | $8.51-$8.93 |
52W Range | $1.54-$9.75 |
Market Cap | $2.9B |
Shares Short | 45M |
Financials
See moreRevenue (12 Mos) | $26.7M |
Revenue Growth (YoY) | 1,704.7% |
Gross Profit (12 Mos) | $14.5M |
Diluted EPS | -$0.49 |
News
See moreYahoo Finance • last month
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
Yahoo Finance • last month
Nuvation Bio Shares Rise 8.4% After Positive Phase 2 Results In Grade-2 IDH1 Glioma
Yahoo Finance • last month
Nuvation Bio to discontinue development of NUV-1511
Yahoo Finance • 2 months ago
Nuvation Bio rises as B. Riley starts at Buy on launch trajectory for lead drug
About
CEO | Dr. David T. Hung M.D. |
CFO | Mr. Philippe Pierre Sauvage |
Address | 1500 Broadway, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 291 |
